TransMedics Group, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$4,159,580
7 notices · 33,766 sh
Oct 2025 to Oct 2026
Reported ·
$4,873,014
12 sales · 1 buy · $1,000,350 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
1 of 12 reported sales carry the 10b5-1 box. Together they are 0.11% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-06-15THOMAS GUNDERSON, Director$722,403
Form 4, 2026-06-17: sold 9,624 at $75.06 Form 4 ↗
2026-03-04GERARDO P HERNANDEZ, Chief Financial Officer$1,065,183
Form 4, 2026-03-04: sold 7,611 at $146.81 Form 4 ↗
2026-03-04STEPHANIE LOVELL, Director$178,491
Form 4, 2026-03-06: sold 1,193 at $149.62 Form 4 ↗
2026-03-04DAVID WEILL, Director$524,295
Form 4, 2026-03-06: sold 3,571 at $146.82 Form 4 ↗
2025-12-03DAVID WEILL, Director$693,211
Form 4, 2025-12-05: sold 5,000 at $138.64 Form 4 ↗
2025-11-25ANIL P RANGANATH, See remarks$435,674
Form 4, 2025-11-26: sold 3,000 at $145.22 Form 4 ↗